Susquehanna International Group’s Acer Therapeutics Inc ACER Stock Holding History

Susquehanna International Group’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-290,372	Closed	-$240K	–	13680
2023 Q3	$240K	Buy	+290,372	New	+$239K	﹤0.01%	9828
2022 Q4	–	Sell	-16,193	Closed	-$23K	–	14149
2022 Q3	$23K	Buy	+16,193	New	+$23.4K	﹤0.01%	12561
2021 Q4	–	Sell	-12,200	Closed	-$31K	–	14169
2021 Q3	$31K	Sell	12,200 -6,821	-36%	-$17.3K	﹤0.01%	12483
2021 Q2	$54K	Sell	19,021 -2,719	-13%	-$7.83K	﹤0.01%	12283
2021 Q1	$68K	Buy	+21,740	New	+$73.9K	﹤0.01%	11976
2019 Q2	–	Sell	-24,623	Closed	-$598K	–	11009
2019 Q1	$598K	Buy	24,623 +12,366	+101%	+$292K	﹤0.01%	5941
2018 Q4	$247K	Buy	+12,257	New	+$282K	﹤0.01%	7368

Other funds holding ACER

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Susquehanna International Group's ACER Position: Q4 2023 in Review

Susquehanna International Group sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 290,372 shares — an estimated $240K sold.

Susquehanna International Group first reported a position in ACER in Q4 2018 and held it in 7 quarters. The position peaked at $598K in Q1 2019. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

Susquehanna International Group reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
Susquehanna International Group sold 290,372 Acer Therapeutics Inc shares in Q4 2023, an estimated $240K.
Susquehanna International Group first reported a position in Acer Therapeutics Inc in Q4 2018 and held it in 7 quarters.
Susquehanna International Group's Acer Therapeutics Inc position peaked at $598K in Q1 2019.
2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.